Ranchi: The state department of state government, medical education and family welfare have emphasized providing benefits under Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-Pmjay) to those who may need hospitalization for Covid-19 treatment.
With a sad country for the possibility of the third wave of infection, the 24-district administration has been directed to ensure that covid patients, which are beneficiaries of the AB-PMJAY, benefit from the scheme.
Bhuvanesh Pratap Singh, Nodal Officer for the third wave of Covid management in Jharkhand, said: “District administration has been directed to ensure that beneficiaries are treated under the scheme.
Awareness campaign will also be carried by the State Health Department in this matter.” Launched in 2018 This scheme promises economically vulnerable families are the cover of the monthly hospitalization of Rs 5 Lakh for various diseases, including cancer, dialynis, neonatal and emergency care.
In June, the Minister of Health Banna Gupta claimed that a total of 1,419 Covid patients at Jharkhand were treated with the AB-PMJay scheme.
From them, 486 took advantage of the scheme during the first wave of the infection that hit Jharkhand in March last year.
A month after attacking pandemics in India, the Ministry of Health’s Union and family welfare included Covid testing and treatment under the AB-Pmjay for 50 recipients of the country’s crore informants.
Even so, the benefits of AB-Pmjay were expanded to a handful of registered beneficiaries that signed Covid in Jharkhand.
“The AB-Pmjay Empalanel Hospital in Jharkhand is under the impression that the Covid-19 treatment package is not included in the scheme.
Therefore, many beneficiaries cannot use the scheme and have to pay from their pockets,” said senior officials at the State Department of Health , In accordance with the union government dashboard, Jharkhand has 35.14 families of the lakh as an AB-PMJAY beneficiary registered and 766 hospitals confirm in all states.
The central dash claim that 486 beneficiaries took advantage of the Covid-19 treatment package between March and July 31 last year.